COVID-19 Vaccines COVID-19 MMR Vaccine Vaccine Development Vaccine Safety Covid Vaccines Respiratory Syncytial Virus (RSV) Covid-19 Vaccines COVID-19 Vaccine Respiratory Syncytial Virus RSV Vaccine Vaccine Access mRNA Vaccines Influenza Vaccine RSV Vaccines Infectious Diseases AstraZeneca Covid Vaccine Preventive Medicine mRNA Technology Types of Vaccines Pneumococcal Vaccines Biotech Industry Dengue Vaccines Childhood Vaccination Production Facilities Vaccine Skepticism Vaccines for Children Program Production Capacity Safety Public Health Policy Flu Vaccine Advisory Committees Covid-19 Malaria Vaccine Coronavirus Vaccines Combination Vaccines Combined Vaccines Flu vaccine mRNA-1083 Healthcare Views Anti-Vaccine Conspiracy Theories Measles Nasal Spray Vaccine Comparison Studies Operation Warp Speed Malaria Immunization Schedule Availability Coronavirus Vaccine Pharmaceutical Industry India Flu Vaccines Safety and Efficacy Covid-19 Vaccination Immunization Practices Adverse Reactions Child Immunization Child Health Biotechnology Clinical Trials Vaccine Sales Skin Cancer Tests COVID-19 Vaccination Dengue Vaccine Respiratory Diseases H5N1 Vaccine mRNA-based Vaccines HPV Vaccine Vaccine Requirements Mpox Vaccine
Record Dupixent sales cushioned weaker vaccines to keep full‑year guidance intact.